Jiuzhitang (000989.) : Jiuzhitang joined forces to build a foundation in 100 years
Jiuzhitang (000989): Deducing the rapid growth of non-net profit, deepening the integration of production and marketing to tap market potential
Jiuzhitang (000989): The recovery in performance in the second quarter clearly deducted net profit from non-return parents, and the year-on-year growth rate was impressive
Jiuzhitang (000989): Performance is in line with expectations, and the pharmaceutical industry is growing at an impressive rate
Jiuzhitang (000989): The potential of a large variety of century-old brands is unleashing long-term growth momentum
Jiuzhitang (000989): The pandemic disrupts revenue pressure and is optimistic about future business optimization+Yifeng empowerment
Jiuzhitang (000989) Company's First Coverage Report: Steady Growth in Performance and Cooperation with Yifeng Pharmacy are Expected to Improve Company and Store Profitability
In-depth report on Jiuzhitang (000989): In 300 years, Jiuzhitang inherited a large variety of long-established brands
Dynamic Review of Jiuzhitang (000989) Company: selected ingenuity Brand actively empowers three strategic plates
Jiuzhitang (000989) Company Dynamic Review: Innovative Drug Projects Steadily Promote State-owned Investments to Boost Development Confidence
Jiuzhitang (000989) annual report comment report: 2019 innovation savings strength 2020 net profit to increase and start a new process
Jiuzhitang (000989) Company Comment: The research results of the invested stem cell project have entered China! The application has been accepted by the Drug Administration
Jiuzhitang (000989): the company's prescription drug performance is under pressure to set up a medical center to promote stem cell business.
Jiuzhitang (000989) comments: further research and development of new drugs for diabetes approved by domestic clinical trials
Jiuzhitang (000989) comments: make great strides forward in stem cell research in Beijing Tiantan Hospital
Jiuzhitang (000989): who will buy Jiuzhitang?
九芝堂(000989):销售调整成效渐显 建议坚定持有
【中投证券】九芝堂:销售调整成效渐显,建议坚定持有
【中投证券】九芝堂:经营战略和营销调整处于改善途中
【东方证券】九芝堂:新总经理上任,业绩突破可期
No Data
No Data